LMY1 self-assembles into nanofibers after being cleaved by matrix metalloproteinase-2 (MMP-2) and has the ability to target cancers that highly express MMP-2, such as lung cancer and CC [159,160]. Here, MMP2 is linked to lung carcinoma.